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Abstract
Background: To test the inflammatory origin of cardiovascular disease, as opposed to its origin in western lifestyle.
Population-based assessment of the prevalences of cardiovascular risk factors and cardiovascular disease in an
inflammation-prone African population, including electrocardiography and ankle-arm index measurement. Comparison
with known prevalences in American and European societies.
Methodology/Principal Findings: Traditional population in rural Ghana, characterised by adverse environmental conditions
and a high infectious load. Population-based sample of 924 individuals aged 50 years and older. Median values for
cardiovascular risk factors, including waist circumference, BMI, blood pressure, and markers of glucose and lipid metabolism
and inflammation. Prevalence of myocardial infarction detected by electrocardiography and prevalence of peripheral arterial
disease detected by ankle-arm index. When compared to western societies, we found the Ghanaians to have more
proinflammatory profiles and less cardiovascular risk factors, including obesity, dysglycaemia, dyslipidaemia, and
hypertension. Prevalences of cardiovascular disease were also lower. Definite myocardial infarction was present in 1.2%
(95%CI: 0.6 to 2.4%). Peripheral arterial disease was present in 2.8% (95%CI: 1.9 to 4.1%).
Conclusions/Significance: Taken together, our data indicate that for the pathogenesis of cardiovascular disease
inflammatory processes alone do not suffice and additional factors, probably lifestyle-related, are mandatory.
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Introduction
The pathogenesis of cardiovascular disease has long been
described as an accumulation of lipids in a dysfunctional
endothelial wall, driven by lifestyle-related factors such as smoking,
dyslipidaemia, dysglycaemia, obesity, and hypertension. Since the
end of the millennium, it has been commonly accepted that
inflammatory processes play a prominent role in atherosclerosis,
reclassifying cardiovascular disease as a chronic inflammatory
disorder [1–3]. Still, the exact balance between lifestyle and
inflammation in its causality has remained unclear. There are both
indications of subendothelial lipid retention [4] and inflammation
[1] as being the primary causative factor.
The lifestyle-related risk factors are mainly present in western
societies, which have experienced an epidemiologic and demo-
graphic transition. In these countries, cardiovascular disease is one
of the major causes of morbidity and the most common cause of
mortality. In developing countries, where these risk factors are
absent, infectious diseases prevail [5]. Without the public health
care of western societies, infectious diseases are highly lethal.
Selectively those individuals that resist the high infectious pressure
by a strong inflammatory response will survive, resulting in a
population expressing a selectively proinflammatory immune
system [6–10]. If cardiovascular disease is an inflammatory
disease, it can be expected to be provoked by such a proin-
flammatory status. Indeed, with the progressing control of lethal
infectious diseases, cardiovascular pathology is becoming more
frequent in developing countries, especially in semideveloped
environments where a western lifestyle concurs with a high
infectious load [5,11,12]. Within western countries, the cardio-
vascular risk of migrants from developing countries remains
elevated [12–14]. Inflammatory markers are used to predict
cardiovascular risk [2,3]. These figures reinforce the dominant role
of inflammation in cardiovascular pathogenesis. However, the
occurrence of cardiovascular disease in the remote and rural
regions of developing countries, where a high infectious load
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induces proinflammatory phenotypes but a western lifestyle is
absent, has infrequently been studied [15–17]. Knowledge on
these data could further unravel the roles of lifestyle and
inflammation as the origins of cardiovascular disease.
We have conducted a large population study in rural Ghana in
West Africa. This study population has only recently started to
experience an epidemiologic transition; the elderly are therefore
not only a subgroup that has survived the pretransitional past, but
have also been exposed to a pretransitional environment during
the largest part of their lives [18]. Previous immunologic and
genetic studies have shown this population to exhibit a proin-
flammatory immune status [8–10]. A previous study in a
comparable population of forager-horticulturalists in Bolivia
provided a first indication of a low prevalence of cardiovascular
disease in populations where a western lifestyle is uncommon [7].
Our study population concerns a purely horticultural population
where lifestyle-related risk factors are even more exceptional. This
study firstly extends previous observations with a detailed
assessment of cardiovascular health in a traditional African
population, including electrocardiography and ultrasound mea-
surement of ankle-arm indexes.
Methods
Research area
The Upper East Region in Ghana is remote, rural, and one of
the least developed regions of the country. The vast majority of the
inhabitants are involved in non-commercial agriculture performed
by manual labor [19]. The yearly per capita income averages US$
135 [20]; 88% of the households lives in poverty [21]. Infectious
diseases are the main causes of death [22].
Since 2002, we have registered and followed a traditional
horticultural population in the Garu-Tempane District in the
Upper East Region occupying a research area of 375 km2 with
approximately 25,000 inhabitants living in circa 40 villages.
Families are polygamous and live as extended families in
compounds. Migration is less than 1% per year. Hospital care is
absent; the nearest physician is at 40 kilometers’ distance.
Vaccination of children has recently been introduced. Sewage
disposal systems are non-existent.
Life expectancy at birth is 59 years. Based on changes in age-
specific mortality rates over time, we have shown epidemiologic
transition in this population to have started only recently with
declines in mortality rates at young ages. Generations aged 50
years or more are unaffected by these changes and conform to a
pretransitional pattern of survival [18].
All inhabitants have been registered and of each are known the
name, age, sex, tribe, location of living. We determined the total
fertility rate, defined as the median number of born children per
postreproductive woman, based on fertility data gathered in the
research area in 2003 [23]. For each household, we determined
the household property value in 2007 according to the Demo-
graphic and Health Survey method [24]. In 2008, we determined
the prevalences of infections by malaria species by PCR of blood
samples and those by helminths and protozoa by PCR of stool
samples [25]. A more elaborate description of this cohort has been
given elsewhere [18,23,24]. This study was conducted within this
cohort.
Study sample
Based on our demographic cohort registration up to 2009, we
targeted all inhabitants aged fifty years and older, counting 2,648
individuals. We consecutively visited the villages in our research
area during two field visits in 2009 and 2010 to approach the
targeted inhabitants. Inclusion was restricted by the duration of
both field visits. To ensure maximal participation, we set up a
mobile field work station in different villages and, if necessary,
brought less mobile participants by car. We included 924
individuals, of whom 607 also underwent electrocardiographic
measurement. Of the approached inhabitants, 4.4% could not
participate due to death of the individual since the last registration,
3.2% refused participation, 2.8% was absent from the research
area during our visit because of migration or travelling, and 4.2%
did not participate for other reasons. At the station, the identity of
the participant was confirmed, the personal data in the cohort
registration was checked, and clinical and electrocardiographic
investigations were performed. In addition, population-wide blood
plasma samples of 266 individuals were available from 2008. On
these, biochemical investigations were performed.
Ethical approval
Ethical approval was given by the Ethical Review Committee of
Ghana Health Services, the Committee Medical Ethics of the
Leiden University Medical Center, and by the local chiefs and
elders. Because of illiteracy, informed consent was obtained orally
from the participants. A consent form was designed with an
explanation on the purpose and conduction of this research
project. This form was to be read out to each participant in his
own language; consent was given verbally in the local language.
Participation was only proceeded after verbal consent of the
participant. The full text of the form was approved by the Ethical
Review Committee of Ghana Health Services.
Clinical investigations
Height and weight were measured by a calibrated length scale
and weighing scale. Body mass index (BMI) was calculated as
weight divided by squared height. Waist circumference was
measured while standing by a measure tape at umbilical level.
In a lying and resting position, blood pressure was measured at
one arm using a calibrated sphygmomanometer and a Littman
stethoscope. Hypertension was determined by these blood
pressures and classified as stage I, stage II, or isolated systolic
hypertension. Hypertension was defined as stage I for systolic
blood pressures of 140 to 160 mmHg and/or diastolic blood
pressures of 90 to 100 mmHg, as stage II for systolic blood
pressures of 160 mmHg onward and/or diastolic blood pressures
of 100 mmHg onward, and as isolated systolic hypertension for
systolic blood pressures of 140 mmHg onward with diastolic blood
pressures below 90 mmHg [26]. Systolic blood pressures were
measured on the dorsalis pedis artery and the posterior tibial
artery at both ankles using a calibrated sphygmomanometer and a
doppler ultrasound machine (Imex DOPCT+). As a measure of
peripheral arterial disease, the ankle-arm index was calculated by
dividing the average systolic pressure of both arteries of each ankle
by the systolic arm pressure. An index below 0.9 of either ankle
indicates peripheral arterial disease [27]. Glucose whole blood
concentration was measured on a capillary blood sample from a
finger (Roche Accutrend Plus). Whole blood concentrations are
circa 11% lower than plasma concentrations.
Biochemical investigations
In 2008, venous blood samples were collected in the morning,
carried on ice, centrifuged within four hours, after which plasma
was kept frozen during storage and transportation at minimally
220uC [9]. Blood samples were analysed in our institution’s
Central Laboratory for Clinical Chemistry. Circulating plasma
levels were determined for triglycerides, total cholesterol, apolipo-
protein-B100 (apoB100), apolipoprotein-A1 (apoA1), C-reactive
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protein (CRP), and interleukin-6 (IL6). Measurements for triglyc-
erides and total cholesterol were performed by colorimetric assays
(Roche Modular P800); for apoB100, apoA1, and CRP by high-
sensitivity immunoturbidimetric assays (Roche Cobas Integra); for
IL6 by sandwich chemiluminescent immunoassay (Randox
Evidence Investigator Biochip). All biochemical markers were
measured in plasma; these concentrations are circa 3% lower than
serum concentrations [27]. ApoB100 is associated with low-density
lipoprotein (LDL) cholesterol, apoA1 with high-density lipoprotein
(HDL) cholesterol. The apoB100 concentration and the ratio of
the concentrations of apoB100 over apoA1 are strongly predictive
risk factors of cardiovascular disease [27]. CRP and IL6 are
proinflammatory markers.
Criteria of cardiovascular risk factors
Cutoff values for cardiovascular risk factors were derived from
the standardly used guidelines of the Adult Treatment Panel III
[27] and the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure [26]. Other
guidelines were used for criteria not included herein, including the
concentration of apoB100 and the ratio of the concentrations of
apoB100 over apoA1 [28] and the concentration of CRP [29]. No
commonly accepted cutoff value is available for IL6.
Electrocardiographic investigations
A twelve-lead electrocardiogram (ECG) was recorded for twenty
seconds in a lying and resting position (Schiller AT-104 PC). All
ECGs were assessed by an experienced cardiologist according to
the Minnesota criteria [30]. The cardiologist was blinded for the
participants’ characteristics other than age and sex. The ECGs
were classified for indications of myocardial infarction, being
absent, possibly or definitively present, and for myocardial
ischaemia-like changes, being absent, minor, or major. For both,
the localisations were classified, being anterior, septal, inferior,
and/or lateral. Merely anteriorly localised ischaemia-like changes
were excluded from analysis (6.4%), as these are reported to be
little specific in African ethnicities [31–33]. Indications of definite
infarction included major and moderate pathological Q waves and
QS patterns (codes 1-1 and 1-2). Indications of possible infarction
included minor pathological Q waves and QS patterns (code 1-3).
Definite ischaemia-like changes included major ST depression, T
wave inversion, and ST elevation (codes 4-1, 4-2, 5-1, 5-2, and 9-
2). Minor ischaemia-like changes included minor ST depression
and T wave inversion and complete left bundle branch block
(codes 4-3, 4-4, 5-3, 5-4, and 7-1).
Reference populations
We compared the findings from our traditional African study
population with those of western societies. As reference popula-
tions, we used three population-based studies in the United States
and Europe for individuals at ages from 45 or 50 years. Data on
the general population in the United States were supplied by the
National Health and Nutrition Examination Survey (NHANES)
for the prevalences of electrocardiographically measured coronary
arterial disease (n=6,201, median age 63 years, 45.3% males)
[34], the prevalence of peripheral arterial disease measured by
ankle-arm index (n=1,868, median age 61 years, 48.4% males),
the prevalence of hypertension (n=2,135, median age 62 years,
46.6% males), and the distributions of cardiovascular risk factors
and inflammatory markers (n=2,323, median age 62 years, 46.1%
males) [35]. Data on the general European population were
provided by a study in Belgium for the prevalences of electrocar-
diographically measured coronary arterial disease (n=29,419,
median age 52 years, 77.7% males) [36] and by the CoLaus Study
in Switzerland for the prevalence of hypertension and the
distributions of cardiovascular risk factors and inflammatory
markers (n=3,515, median age 61 years, 45.4% males) [37,38].
In the cases of Belgian prevalences of electrocardiographic
abnormalities and the Swiss distribution of IL6, only sex-split
data were available. For comparability, both were graphically
displayed as averages weighed by the number of individuals per
sex. For the reference populations, within the definition of
hypertension was included the use of antihypertensive medication,
within the definition of diabetes was included the use of
antidiabetic medication, and within the definition of elevated
levels of total cholesterol or LDL cholesterol was included the use
of antidyslipidaemic medication. Otherwise, applied definitions
and cutoff values were identical as described for our study.
Analyses
Confidence intervals were calculated by Wilson’s formula for
prevalences and using the binomial distribution for medians.
Individual associations of presence of cardiovascular disease with
cardiovascular risk factors, inflammation, and socio-economic
status were tested by logistic regression analysis, including age and




Table 1 provides a description of the demographic, socioeco-
nomic, and infectious characteristics of the study sample that
participated in the electrocardiographic investigations. The
overrepresentation of women and a heightened socioeconomic
status compared to the total cohort population are results of the
selection on age. Otherwise, the baseline characteristics of the
study sample that participated in the electrocardiographic
investigations were similar to those of the study samples that
participated in the clinical and biochemical investigations as well
as to those throughout the total cohort population.
Cardiovascular risk factors
Table 2 summarises the clinical and biochemical investigations
for the detection of cardiovascular risk factors concerning body
size, blood pressure, glucose metabolism, lipid metabolism, and




Age median (iqr) years 66 (56–74)
Male sex n (%) 169 (27.5)
Total fertility rate median (iqr) children per woman 7 (6–9)
Household property value median (iqr) US$ 1,050 (500–1,936)
Individuals infected %
by malaria species 0077.5%
by helminths 0021.4%
by protozoa 0100.0%
A description of the general characteristics is given for the study sample aged
50 years and older that participated in the electrocardiographic investigations.
Total fertility rate is expressed as the number of born children per woman aged
45 years or more. Iqr – interquartile range.
doi:10.1371/journal.pone.0046855.t001
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inflammation. Hypertension was classified as stage I, stage II, or
isolated systolic hypertension. Plasma glucose concentrations were
used to detect elevated cardiovascular risk from 5.6 mmol/l
onward and to detect diabetes mellitus from 7.0 mmol/l onward
[27]. The balance between HDL and LDL cholesterol was
represented by the ratio of the plasma concentrations of apoB100
over apoA1. As markers of the inflammatory status, plasma
concentrations of CRP and IL6, both proinflammatory cytokines,
were used. In our study population, median levels of cardiovas-
cular risk factors were low and prevalences of obesity, hyperten-
sion, dysglycaemia or diabetes, and dyslipidaemia were low. The
prevalence of moderately elevated levels of CRP was low.
In Figure 1, the distributions of cardiovascular risk factors in our
study population are compared to those in the western reference
populations. Over the age of 50 years, in Ghana lower median
values or prevalences were found for all cardiovascular risk factors
describing body size, blood pressure, and glucose and lipid
metabolism compared to the United States and Europe. For the
inflammatory markers, median levels of CRP were lower, but
levels of IL6 were higher.
Cardiovascular disease
Table 3 shows the prevalences of cardiovascular disease in our
study population. We used electrocardiography to detect coronary
arterial disease, classified as possible or definite myocardial
infarction and minor or definite myocardial ischaemia-like
changes. Prevalences of myocardial infarction and myocardial
ischaemia-like changes were low. We used measurement of ankle-
arm index to detect peripheral arterial disease, defined as an ankle-
arm index below 0.9 of either leg. The prevalence of peripheral
arterial disease was low; median ankle-arm indexes were high.
As shown in Figure 2, the prevalences of both coronary and
peripheral arterial disease in Ghana were lower compared to the
western reference populations, using identical clinical and
electrocardiographic criteria. A similar pattern was found for
myocardial ischaemia-like changes. Moreover, Ghanaian preva-
lences of coronary and peripheral arterial disease increased less
over age.
Individual associations
For the individuals affected by cardiovascular disease, no
associations could be found with cardiovascular risk factors,
inflammation, or socioeconomic status.
Discussion
This study aimed to determine cardiovascular health in a
traditional population in Ghana in West Africa after the age of 50
years. Our study population is demographically and economically
characterised by an underdeveloped pretransitory status relative to
western countries. In this adverse environment, individuals are
exposed to a high infectious load, favouring survival of those with a
proinflammatory immune status. Compared to American and
European societies, we indeed found common proinflammatory
profiles, but low prevalences of cardiovascular risk factors
associated with a western lifestyle, including obesity, hypertension,
dysglycaemia or diabetes, and dyslipidaemia. In this population,
prevalences of coronary and peripheral arterial disease measured
by electrocardiography and ankle-arm index were correspondingly
low.
For some cardiovascular risk factors no formal determination
was possible, including smoking behaviour, alcohol use, diet
composition, and lack of physical exercise. Tobacco is self-grown
and beer is self-brewed. The availability of both is dependent on
the harvest, as commercial distribution of cigarettes and alcoholic
beverages is locally absent. Their regular use is more or less a
social taboo. Based on our long-lasting experiences, regular
smoking and drinking among men is common, estimated to
concern one third and two thirds of the population, respectively,
but the quantities are likely to be limited when compared to
developed countries. Women do not publicly smoke or drink, but
we presume women to exhibit these behaviours privately in
smaller proportions. Physical inactivity is exceptional and western
diet is absent. It should be noted that most inhabitants in the
research area provide for their own living by non-commercial
agriculture performed by manual labour. The scarcity of electricity
and machinery necessitates physical exercise for farming and
housekeeping. Transportation is almost always by foot or bicycle.
The savannah climate is dry with only one rainy season of variable
duration, hindering agriculture. The limited variety of crops that
can be grown in this environment – e.g. millet, corn, okra, beans,
Table 2. Cardiovascular risk factors in the Ghanaian study
sample (age$50 years).
Males Females
Clinical investigations (n= 480) (n= 444)
Waist circumference cm 77 (73–81) 76 (72–80)
$102 (=) or $88 cm (R) 0.0% (0.0–0.8) 7.4% (5.3–10.3)
Body mass index kg/m2 18.1 (16.5–19.4) 18.1 (16.6–19.7)
$25.0 kg/m2 0.2% (0.0–1.2) 1.4% (0.6–2.9)
Diastolic blood pressure mmHg 75 (70–80) 70 (65–75)
Systolic blood pressure mmHg 120 (110–135) 120 (110–135)
Hypertension
stage I 16.7% (13.6–20.3) 13.7% (10.8–17.3)
stage II 9.0% (6.7–11.9) 8.8% (6.5–11.8)
isolated systolic 15.7% (12.7–19.2) 16.2% (13.1–19.9)
Glucose mmol/l 3.8 (3.3–4.4) 4.0 (3.6–4.5)
$5.6 mmol/l 6.0% (4.3–8.6) 6.3% (4.5–9.1)
$7.0 mmol/l 1.0% (0.4–2.4) 1.4% (0.6–3.0)
Biochemical investigations (n= 94) (n= 172)
Triglycerides mmol/l 0.80 (0.68–0.95) 0.95 (0.76–1.21)
$1.7 mmol/l 4.3% (1.7–10.4) 6.4% (3.6–11.1)
Total cholesterol mmol/l 3.04 (2.49–3.51) 3.24 (2.81–3.74)
$5.2 mmol/l 1.1% (0.2–5.8) 1.7% (0.6–5.0)
ApoB100 g/l 0.54 (0.47–0.64) 0.58 (0.49–0.69)
$0.9 g/l 2.1% (0.6–7.4) 2.9% (1.3–6.7)
Ratio of apoB100 over apoA1 0.58 (0.45–0.68) 0.52 (0.43–0.66)
$0.9 (=) or $0.8 (R) 5.3% (2.3–11.9) 12.8% (8.7–18.7)
C-reactive protein mg/l 1.06 (0.34–3.77) 0.95 (0.44–2.35)
3.0–10.0 mg/l 19.1% (12.5–28.3) 11.6% (7.7–17.3)
Interleukin-6 ng/l 2.28 (1.47–3.23) 1.84 (1.37–2.42)
Distributions are given as medians (interquartile ranges), prevalences are given
as percentages (95% confidence intervals) meeting the indicated risk factor
criteria, all for those aged 50 years and older. Hypertension has been classified
as stage I for diastolic blood pressures of 90 to 100 mmHg and/or systolic blood
pressures of 140 to 160 mmHg, as stage II for diastolic blood pressures from
100 mmHg onward and/or systolic blood pressures from 160 mmHg onward,
and as isolated systolic for systolic blood pressures from 140 mmHg onward
with diastolic blood pressures lower than 90 mmHg. ApoA1 – apolipoprotein-
A1. ApoB100 – apolipoprotein-B100.
doi:10.1371/journal.pone.0046855.t002
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onions, and tomatoes – and the omnipresent low social economic
standard restrict the ingestion of fat and glucose. Commercial
distribution of conserved food has remained financially unattain-
able for most.
Although the prevalence of cardiovascular disease was low,
cardiovascular disease was not absent in our study population.
This indicates that low prevalences of obesity, dysglycaemia or
diabetes, and dyslipidaemia do not entirely prevent the occurrence
of cardiovascular disease. The presence of hypertension is
Figure 1. Cardiovascular risk factors in the Ghanaian study sample compared with the American and European reference
populations over age. Distributions over age are given as medians. Prevalences over age of hypertension are given as percentages, including
stage I, stage II, and isolated systolic hypertension. Values for age represent midpoints of age intervals, because of different age groups used for the
reference populations.
doi:10.1371/journal.pone.0046855.g001
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relatively uncommon, but still present in about one fifth of the
population. It may be relatively important for cardiovascular
pathogenesis in this population. Moreover, some do smoke and
drink, but the consumption and attribution are difficult to
estimate. Other factors independent of lifestyle, such as genotype,
may also render individuals susceptible. In line with this, for those
few who are affected, we have been unable to find any association
with the cardiovascular risk factors as measured in this study. In
this study, genotypes have not been assessed. Recently, we have
collected mouth swabs in our study population for genetic analyses
in future research.
Previous research on risk factors of cardiovascular disease has
shown that in Africa, equal to western societies, cardiovascular
disease can be mainly attributed to obesity, dysglycaemia,
dyslipidaemia, smoking, and hypertension [11–13]. Pathogenetic
mechanisms have been described by which lifestyle-related risk
factors drive cardiovascular disease [4,40]. However, these studies
are based on urban regions with westernised risk profiles. Data
from populations without a western lifestyle, as our study
population, are needed to confirm that these lifestyle-related risk
factors are primarily responsible for cardiovascular disease to
develop.
In our study population, all individuals were infected by
protozoa, while infections by helminths and malaria species were
highly endemic. This high infectious load, together with little
public and personal hygiene and little medical care, renders
infectious diseases as the main cause of death. Previously, we have
shown that selectively those individuals that express a proin-
flammatory immune system survive up to older ages [8–10]. This
selection of a proinflammatory status is confirmed by the higher
levels of the proinflammatory cytokine interleukin-6 (IL6) in our
study population compared to western societies. Different from
IL6, we found lower levels of the inflammatory marker C-reactive
protein (CRP) in our study population compared to western
societies. Plasma levels of CRP are highly elevated during acute
infections. During chronic, subclinical infections, CRP levels may
not be elevated. In populations endemic for infections by malaria
and helminth species, these levels can be rather within the normal
range [41–43]. Probably, in these instances, a systemic inflamma-
tory response is not elicited, as the immune system has become
effectively able to restrain the pathogens or has become tolerant.
Distinctive to chronic infections, however, chronic non-infectious
inflammatory disorders are associated with moderately elevated
levels of CRP [29]. Likely, instead of being a risk factor, these
moderately elevated levels are an effect of the pathophysiological
inflammatory processes and thus a marker of cardiovascular
disease [44–46]. In line with this, we found less moderately
elevated levels in our study population compared to western
societies. Similar results have been obtained in other developing
populations with high rates of infectious diseases in Southern
America [47,48]. The comparisons of CRP and IL6 levels with
those in western societies are consistent when using other reports
from western societies [49,50].
Although we show that inflammation alone is not sufficient to
cause cardiovascular disease, inflammation still plays a major role
in its pathogenesis. This is reflected by the high prevalences of
cardiovascular disease in regions where a western lifestyle
coincides with a high infectious load [5,11–13]. In addition,
migrants from developing regions are affected by cardiovascular







definite 1.8% (0.6–5.1) 0.9% (0.4–2.3)
possible 4.2% (2.0–8.4) 2.1% (1.1–3.8)
Myocardial ischaemia-like
changes
definite 13.7% (9.3–19.7) 10.0% (7.6–13.2)
minor 2.4% (0.9–6.0) 3.2% (1.9–4.6)
Clinical investigations (n=480) (n= 444)
Ankle-arm index 1.16 (1.10–1.24) 1.14 (1.06–1.22)
Peripheral arterial disease 2.3% (1.3–4.1) 3.4% (2.1–5.5)
Prevalences are given as percentages (95% confidence intervals) and
distributions are given as medians (interquartile ranges), all for those aged 50
years and older. Peripheral arterial disease has been defined as an ankle-arm
index below 0.9.
doi:10.1371/journal.pone.0046855.t003
Figure 2. Cardiovascular disease in the Ghanaian study sample compared with the American and European reference populations
over age. Prevalences over age are given as percentages. Peripheral arterial disease has been defined as an ankle-arm index below 0.9. Definite
myocardial infarction has been detected by electrocardiography. Values for age represent midpoints of age intervals, because of different age groups
used for the reference populations.
doi:10.1371/journal.pone.0046855.g002
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disease in western societies at younger ages and with higher
mortality [11–14]. These populations are likely to have developed
a proinflammatory immune status and are thereby probably more
susceptible to develop inflammatory disease, such as cardiovascu-
lar disease. Even in developed countries, such predisposing
processes can be effectuated through adverse environmental
conditions [51,52]. These notions are supported by the observa-
tion of higher levels of CRP in African Americans compared to
white Americans [50,53] and the beneficial effects of antidyslipi-
daemic therapy in individuals with elevated CRP [54].
This study has several limitations. First, for the registration of
glucose and lipid parameters, blood samples have been taken in
the morning. Although breakfast is uncommon, participants have
not been requested to fast. Observed glucose and triglyceride levels
could have been overestimated in this population and fasted values
could be even lower than reported here. This reinforces the
present interpretation of the study. Second, we have not been able
to cover all cardiovascular risk factors, leaving smoking, alcohol
use, diet composition, physical exercise, and genetic factors. Third,
because of selection on age, women are overrepresented,
demanding some prudence in the interpretation of the data for
men.
Electrocardiographic criteria are reliable for the distinction of
myocardial infarction. However, myocardial ischaemia-like chang-
es are less distinctive [36]. Apart from coronary arterial disease,
other disorders can effectuate these changes in repolarisation [33].
Moreover, in African ethnicities, these changes in repolarisation
are little specific for coronary arterial disease [31,32,55].
Therefore, true prevalences of cardiovascular disease might be
even lower than reported in this study. Unknown as well remain
possible confounding selective processes. In our study population,
the mortality due to cardiovascular disease is undetermined. If
high, those affected could have deceased before being detected.
When a selection exists for physically fit individuals to survive,
those prone to develop cardiovascular disease might not live to
older ages. However, these suppositions are contradicted by our
observation of the few cases that were found with a slightly
increasing trend over age.
This study determines the population-wide prevalences of
peripheral and coronary arterial disease in a traditional African
population by measurement of ankle-arm index and electrocardi-
ography. These prevalences have not been described earlier for
developing populations without a western lifestyle in relation to
lifestyle and inflammation. First, this knowledge is of importance
for underdeveloped populations themselves to guide preventive
and curative policies. Worldwide, the prevalence of cardiovascular
disease is rapidly increasing, especially in developing regions
parallel to urbanisation and westernisation [11,12]. As we show,
also in these regions, it can be worthwhile to emphasise on the
research and prevention of lifestyle-related risk factors for the
control of cardiovascular disease. Second, this knowledge is of
equal importance of western societies. Of today’s African
Americans, a large majority is genetically related to traditional
populations in West Africa [39]. Predominantly these and other
migrant populations suffer from a burden of cardiovascular
disease, even after lifelong residence in western society [11–14].
It remains unclear to what extent this disparity can be explained
by biological, socioeconomic, and cultural differences. Possibly,
these ethnicities have been programmed through selection or
through development to be more proinflammatory. Nonetheless,
our study confirms that preventive and curative policies may be
expected to be successful when addressing particular aspects of
lifestyle.
In conclusion, we have shown that in a traditional non-western
African population, despite promotion of inflammation, cardio-
vascular disease infrequently develops because of low prevalences
of lifestyle-related cardiovascular risk factors compared to Amer-
ican and European societies. Together, these results indicate that
cardiovascular disease is not primarily caused by inflammatory
processes, but a western lifestyle is a prerequisite for its
development. This provides even further arguments to prioritise
the promotion of a healthy lifestyle, both in developed and in
developing countries.
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